General Information of Drug (ID: DMBLHIS)

Drug Name
Ofranergene obadenovec
Synonyms VB-111
Indication
Disease Entry ICD 11 Status REF
Ovarian cancer 2C73 Phase 3 [1]
Glioblastoma of brain 2A00.00 Phase 2 [2]
Drug Type
Gene therapy
Cross-matching ID
TTD ID
DU60ND
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT03398655) A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04406272) VB-111 in Surgically Accessible Recurrent/Progressive GBM. U.S. National Institutes of Health.